RI
GPCR icon

RTW Investments’s Structure Therapeutics GPCR Stock Holding History

RTW Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.3M Buy
+1,607,507
New +$71.1M 0.74% 38
2026
Q1 		– Sell
-100,000
Closed -$6.96M – 92
2025
Q4 		$6.96M Buy
+100,000
New +$4.08M 0.07% 77
2025
Q1 		– Sell
-125,000
Closed -$3.39M – 72
2024
Q4 		$3.39M Hold
125,000
– – 0.05% 64
2024
Q3 		$5.49M Hold
125,000
– – 0.08% 57
2024
Q2 		$4.91M Buy
+125,000
New +$5.13M 0.08% 56

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RTW Investments's GPCR Position: Q2 2026 in Review

RTW Investments opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 1,607,507 shares worth $86.3M. The stake represents 0.74% of the portfolio and ranks #38 among its holdings. This is a return to the name: RTW Investments previously reported a position in GPCR as recently as Q4 2025.

RTW Investments first reported a position in GPCR in Q2 2024 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • RTW Investments held 1,607,507 shares of Structure Therapeutics worth $86.3M as of Q2 2026.
  • Structure Therapeutics was a new RTW Investments position in Q2 2026.
  • Structure Therapeutics made up 0.74% of RTW Investments's portfolio in Q2 2026, its #38 holding.
  • RTW Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.